Board changes: two new independent directors join, one resigns

Management Changes View source PDF Explain this filing

WINDLAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹945.50

prior close

₹950.30

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-1.8% vs market

Pharmaceuticals peers, median of 168sector-0.3%-1.3% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.0

10m

-3.0

15m

-3.5

30m

-2.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.2-1.8-0.3-1.3

Next day

-3.3+0.9-4.2-0.3-3.0

-2.4-0.8-1.6-1.2-1.2

-3.5-0.1-3.4-1.0-2.5

-5.6-1.7-3.9-2.6-3.1

-6.1-4.3-1.8-3.8-2.3

-6.4-7.5+1.1-6.5+0.1

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Windlas Biotech's board appointed Mr. Aashish Mehra and Mr. Soni Saran Singh as Independent Directors for five years from Oct 12, 2026. Mr. Vivek Dhariwal, Independent Director and Board Chairman, resigned citing personal reasons and stepped down from the Nomination and Remuneration and CSR committees. All appointments need shareholder approval.

Likely market impact

Routine board reshuffle with one independent director exit for personal reasons and two new appointments; unlikely to materially impact the stock.